Agency says vaccine benefits outweigh risks
Europe's medicines watchdog on Tuesday said the benefits of AstraZeneca's COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about blood clots. Emer McCarthy reports.